Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;55(2):389-398.
doi: 10.1007/s11255-022-03328-9. Epub 2022 Aug 11.

Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China

Shuman Tao  1 , Xiuyong Li  2 , Zhi Liu  3 , Youwei Bai  4 , Guangrong Qian  5 , Han Wu  6 , Ji Li  7 , Yuwen Guo  8 , Shanfei Yang  9 , Lei Chen  10 , Jian Yang  11 , Jiuhuai Han  12 , Shengyin Ma  13 , Jing Yang  14 , Linfei Yu  15 , Runzhi Shui  16 , Xiping Jin  17 , Hongyu Wang  18 , Fan Zhang  19 , Tianhao Chen  20 , Xinke Li  21 , Xiaoying Zong  22 , Li Liu  23 , Jihui Fan  24 , Wei Wang  25 , Yong Zhang  26 , Guangcai Shi  27 , Deguang Wang  28
Affiliations

Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China

Shuman Tao et al. Int Urol Nephrol. 2023 Feb.

Abstract

Background: Chronic kidney disease-mineral bone disorder (CKD-MBD) is a common comorbidity in patients with CKD. The study aims to describe the control rates of serum-corrected calcium (Ca), phosphate (P) and intact parathyroid hormone (iPTH) and its risk factors among maintenance hemodialysis (MHD) patients in Anhui Province of China.

Methods: The study was conducted in 27 hemodialysis centers of Anhui Province between January 1st 2020 and December 31th 2020. Chi-square test was used to compare the control rates of serum-corrected Ca, P and iPTH between the present study and DOPPS 4 or Anhui Province in 2014. Binary logistic regression analysis was used to explore the risk factors of the control rates of serum-corrected Ca, P and iPTH.

Results: A total of 3 025 MHD patients were recruited in this study, with a mean age of 54.8 (SD: 12.8) years, and 60.1% were males. According to the Chinese Diagnosis and Treatment Guidelines for CKD-MBD, the control rates of serum-corrected Ca, P and iPTH in the present study were 57.9%, 20.0% and 56.0%, respectively. Based on KDOQI guidelines (2003), the control rates of the above indicators were 43.1%, 35.3% and 22.3%, respectively. The control rates of serum-corrected Ca, P and iPTH in this study were lower than those of DOPPS 4 (P < 0.001). Compared to the results of Anhui Province in 2014, the control rate of corrected Ca was higher (P < 0.001) and the control rate of iPTH was lower (P = 0.005). Age, residential area, BMI, dialysis vintage, albumin and hemoglobin levels were factors of serum-corrected Ca, P and iPTH not within target range.

Conclusion: The control rates of serum-corrected Ca, P and iPTH in MHD patients in Anhui Province are relatively low. Monitoring and management should be strengthened to improve the prognosis of patients undergoing dialysis.

Keywords: Chronic kidney disease; Hemodialysis; Mineral and bone disorder.

PubMed Disclaimer

References

    1. Chen H, Wang DG, Qian GR, Huang YY, Hu B, Wang CF et al (2015) Investigation of maintenance hemodialysis patients with mineral and bone disorder in Anhui Province. Chin J Nephrol 31(7):509–515. https://doi.org/10.3760/cma.j.issn.1001-7097.2015.07.006 - DOI
    1. Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H et al (2019) China kidney disease network (CK-NET) 2015 annual data report. Kidney Int Suppl 9(1):e1–e81. https://doi.org/10.1016/j.kisu.2018.11.001 - DOI
    1. Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H, Wang H, CK-NET Work Group (2020) China kidney disease network (CK-NET) 2016 annual data report. Kidney Int Suppl 10(2):e97–e185. https://doi.org/10.1016/j.kisu.2020.09.001 - DOI
    1. National Clinical Research Center For Kidney Disease (2019) Summary of Chinese guidelines for the diagnosis and treatment of chronic kidney disease with mineral and bone abnormalities in. J Nephrol Daily Transplant 28(1):52–57. https://doi.org/10.3969/j.issn.1006-298X.2019.01.012 - DOI
    1. Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30(9):1542–1551. https://doi.org/10.1093/ndt/gfv099 - DOI

LinkOut - more resources